Clinical Trial Update: Safety of Xeloda in Solid Tumours

View source ↗

Summary

Clinical trial update assessing the safety of Xeloda (capecitabine) in solid tumors, including metastatic breast cancer and colon cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colon Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Breast Cancer, Colon Cancer | Status: COMPLETED